Supporting evidence
Metformin × Fasting blood sugar (FBS)
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Limited
Ranolazine improves glycaemic control when added to metformin in T2DM patients
- Comparison
- Patients receiving metformin as monotherapy. · Patients receiving metformin plus ranolazine.
- Duration / follow-up
- 4 weeks
Study 2 · Included
Sitagliptin with Metformin Improves Metabolic Health
Rct
- Comparison
- Patients received sitagliptin (100 mg/d) plus metformin (2000 mg/d). · Patients received metformin alone (2000 mg/d).
- Duration / follow-up
- 12 weeks
Relevant effects
Mean difference
18 · 0.03
Mean difference
0.67 · 0.017
Mean difference
13 · 0.052
Mean difference
0.21 · 0.896
Study 3 · Included
Vildagliptin and Metformin Improve Glycemic Control in Type 2 Diabetes
Rct
- Comparison
- Patients received 50 mg of vildagliptin orally twice daily. · Patients received 500 mg of metformin orally twice daily with meals, with dosage adjustable.
- Duration / follow-up
- 26 weeks
Relevant effects
Absolute change
110.62 · 0.001
Absolute change
110.62 · 0.001